feed,title,long_url,short_url
Benzinga,FDA Approves FINTEPLAÂ® (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome,https://www.benzinga.com/pressreleases/20/06/g16399850/fda-approves-fintepla-fenfluramine-for-the-treatment-of-seizures-associated-with-dravet-syndrome,https://j.mp/2NuKiMv
Benzinga,Fusion Acquisition Corp. Announces Pricing of $305 Million Initial Public Offering,https://www.benzinga.com/pressreleases/20/06/g16399849/fusion-acquisition-corp-announces-pricing-of-305-million-initial-public-offering,https://j.mp/31hP1Jr
